Circulating tumor DNA for monitoring classic Hodgkin lymphoma patients: Correlation with FDG-PET/CT

被引:7
作者
Fernandez, Sara [1 ]
Cereceda, Laura [1 ,2 ]
Diaz, Eva [1 ]
Figueroa, Sasha [1 ,2 ]
Reguera, Laura [3 ]
Menendez, Victoria [1 ]
Solorzano, Jose L. [2 ]
Montalban, Carlos [4 ]
Estevez, Monica [4 ]
Garcia, Juan F. [1 ,2 ,5 ]
机构
[1] Fdn MD Anderson Int Espana SL Madrid, Translat Res, Madrid, Spain
[2] MD Anderson Canc Ctr Madrid, Pathol Dept, C Arturo Soria 270, Madrid 28033, Spain
[3] MD Anderson Canc Ctr Madrid, Nucl Med Dept, Madrid, Spain
[4] MD Anderson Canc Ctr Madrid, Hematol Dept, Madrid, Spain
[5] ISCIII, Ctr Biomed Network Res Canc CIBERONC, Madrid, Spain
来源
EJHAEM | 2024年 / 5卷 / 01期
关键词
Hodgkins lymphoma; lymphoid malignancies; minimal residual disease; MUTATIONS; GENE;
D O I
10.1002/jha2.826
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The value of circulating tumor DNA (ctDNA) as a biomarker of disease activity in classic Hodgkin lymphoma (cHL) patients has not yet been well established. By profiling primary tumors and ctDNA, we identified common variants between primary tumors and longitudinal plasma samples in most of the cases, confirming high spatial and temporal heterogeneity. Although ctDNA analyses mirrored HRS cell genetics overall, the prevalence of variants shows that none of them can be used as a single biomarker. Conversely, the estimation of hGE/mL, based on measures of total ctDNA, reflects disease activity and is almost perfectly correlated with standard parameters such as PET/CT that are associated with refractoriness.
引用
收藏
页码:70 / 75
页数:6
相关论文
共 16 条
[1]   Somatic mutations of cell-free circulating DNA detected by targeted next-generation sequencing and digital droplet PCR in classical Hodgkin lymphoma [J].
Bessi, Lucile ;
Viailly, Pierre-Julien ;
Bohers, Elodie ;
Ruminy, Philippe ;
Maingonnat, Catherine ;
Bertrand, Philippe ;
Vasseur, NasrinSarafan ;
Beaussire, Ludivine ;
Cornic, Marie ;
Etancelin, Pascaline ;
Camus, Vincent ;
Picquenot, Jean-Michel ;
Tilly, Herve ;
Stamatoullas, Aspasia ;
Jardin, Fabrice .
LEUKEMIA & LYMPHOMA, 2019, 60 (02) :498-502
[2]   How to Obtain a High Quality ctDNA in Lymphoma Patients: Preanalytical Tips and Tricks [J].
Bourbon, Estelle ;
Alcazer, Vincent ;
Cheli, Estelle ;
Huet, Sarah ;
Sujobert, Pierre .
PHARMACEUTICALS, 2021, 14 (07)
[3]   Circulating cell-free DNA in hematological malignancies [J].
Buedts, Lieselot ;
Vandenberghe, Peter .
HAEMATOLOGICA, 2016, 101 (09) :997-999
[4]   Circulating tumor DNA in primary mediastinal large B-cell lymphoma versus classical Hodgkin lymphoma: a retrospective study [J].
Camus, Vincent ;
Viennot, Mathieu ;
Leveque, Emilie ;
Viailly, Pierre-Julien ;
Tonnelet, David ;
Veresezan, Elena-Liana ;
Drieux, Fanny ;
Etancelin, Pascaline ;
Dubois, Sydney ;
Stamatoullas, Aspasia ;
Tilly, Herve ;
Bohers, Elodie ;
Jardin, Fabrice .
LEUKEMIA & LYMPHOMA, 2022, 63 (04) :834-844
[5]   Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study [J].
Camus, Vincent ;
Viennot, Mathieu ;
Lequesne, Justine ;
Viailly, Pierre-Jullien ;
Bohers, Elodie ;
Bessi, Lucile ;
Marcq, Benedicte ;
Etancelin, Pascaline ;
Dubois, Sydney ;
Picquenot, Jean Michel ;
Veresezan, Elena-Liana ;
Cornic, Marie ;
Burel, Lucie ;
Loret, Justine ;
Becker, Stepha ;
Decazes, Pierre ;
Lenain, Pascal ;
Lepretre, Stephane ;
Lemasle, Emilie ;
Lanic, Helene ;
Menard, Anne-Lise ;
Contentin, Nathalie ;
Tilly, Herve ;
Stamatoullas, Aspasia ;
Jardin, Fabrice .
HAEMATOLOGICA, 2021, 106 (01) :154-162
[6]   Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma [J].
Camus, Vincent ;
Stamatoullas, Aspasia ;
Mareschal, Sylvain ;
Viailly, Pierre-Julien ;
Sarafan-Vasseur, Nasrin ;
Bohers, Elodie ;
Dubois, Sydney ;
Picquenot, Jean Michel ;
Ruminy, Philippe ;
Maingonnat, Catherine ;
Bertrand, Philippe ;
Cornic, Marie ;
Tallon-Simon, Valerie ;
Becker, Stephanie ;
Veresezan, Liana ;
Frebourg, Thierry ;
Vera, Pierre ;
Bastard, Christian ;
Tilly, Herve ;
Jardin, Fabrice .
HAEMATOLOGICA, 2016, 101 (09) :1094-1101
[7]   Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study [J].
Fernandez-Miranda, Ismael ;
Pedrosa, Lucia ;
Llanos, Marta ;
Franco, Fernando F. ;
Gomez, Sagrario ;
Martin-Acosta, Paloma ;
Garcia-Arroyo, Francisco R. ;
Guma, Josep ;
Horcajo, Beatriz ;
Ballesteros, Ana K. ;
Galvez, Laura ;
Martinez, Natividad ;
Marin, Miguel ;
Sequero, Silvia ;
Navarro, Marta ;
Yanguas-Casas, Natalia ;
Calvo, Virginia ;
Rueda-Dominguez, Antonio ;
Provencio, Mariano ;
Sanchez-Beato, Margarita .
CLINICAL CANCER RESEARCH, 2023, 29 (01) :209-220
[8]   Genomic analyses of microdissected Hodgkin and Reed-Sternberg cells: mutations in epigenetic regulators and p53 are frequent in refractory classic Hodgkin lymphoma [J].
Mata, Elena ;
Fernandez, Sara ;
Astudillo, Aurora ;
Fernandez, Ruben ;
Garcia-Cosio, Monica ;
Sanchez-Beato, Margarita ;
Provencio, Mariano ;
Estevez, Monica ;
Montalban, Carlos ;
Piris, Miguel A. ;
Garcia, Juan F. .
BLOOD CANCER JOURNAL, 2019, 9 (3)
[9]   Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets [J].
Mata, Elena ;
Diaz-Lopez, Antonio ;
Martin-Moreno, Ana M. ;
Sanchez-Beato, Margarita ;
Varela, Ignacio ;
Mestre, Maria J. ;
Santonja, Carlos ;
Burgos, Fernando ;
Menarguez, Javier ;
Estevez, Monica ;
Provencio, Mariano ;
Sanchez-Espiridion, Beatriz ;
Diaz, Eva ;
Montalban, Carlos ;
Piris, Miguel A. ;
Garcia, Juan F. .
ONCOTARGET, 2017, 8 (67) :111386-111395
[10]   Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells [J].
Reichel, Jonathan ;
Chadburn, Amy ;
Rubinstein, Paul G. ;
Giulino-Roth, Lisa ;
Tam, Wayne ;
Liu, Yifang ;
Gaiolla, Rafael ;
Eng, Kenneth ;
Brody, Joshua ;
Inghirami, Giorgio ;
Carlo-Stella, Carmelo ;
Santoro, Armando ;
Rahal, Daoud ;
Totonchy, Jennifer ;
Elemento, Olivier ;
Cesarman, Ethel ;
Roshal, Mikhail .
BLOOD, 2015, 125 (07) :1061-1072